The choice to invest in vaccines rather than in weapons; in treatments for rare diseases rather than in speculative consumer products; in long-term infrastructure rather than in short-term optics—these are not technical decisions. They are moral decisions . . .

Biotech in the Balance by Dr. Jeremy M. Levin shows why the next lifesaving medicines may not arrive on time, and what we can do about that in a period of political change. 

Editorial Review:

"Biotech in the Balance is a beautifully written book by one of the heroes in this field. There are many valuable lessons in this book. For a company to be successful, it takes far more than great science: excellent leadership, long term vision, thoughtful investors, putting patients first, and other factors as Dr Levin outlines in his 10 commitments." — Robert Langer, Institute Professor, Massachusetts Institute of Technology; Founder, Moderna Inc.